Neuropeptide K (NPK) is an N-terminally extended derivative of neurokinin A (NKA) that can be a final product in the posttranslational processing of (3-preprotachykinin. A rat salivation bioassay was used to demonstrate potent effects of NPK at low doses, while effects due to NKA were much weaker at higher doses. The rank order of potency of (3-preprotachykinin-derived peptides on salivation responses was NPK > substance P > NKA »P f3-preprotachykinin-(72-96)-peptide. The time course of the NPK response was longer than that observed with substance P. The responses elicited by NPK were blocked by the tachykinin antagonist [D-Pro2, D-Trp7 91substance P but not by atropine. In peptide coinfusion studies, NPK strikingly potentiated the salivation responses elicited by substance P. NPK in vitro displayed a 100 times lower potency than substance P in displacing 3H-labeled substance P binding in submandibular gland membranes, a tissue rich in SP-P type (NK-1) receptors. The possible cellular mechanisms by which NPK stimulates salivary gland secretion are discussed. We conclude that NPK and substance P may be cotransmitters derived by posttranslational processing of (3-preprotachykinin.The tachykinin peptides are a family of structurally related neuropeptides that are under consideration as neurotransmitter or neuromodulatory substances. Mammalian peptides in this family include substance P (SP), neurokinin A (NKA), neuropeptide K (NPK), and neurokinin B (NKB; for review, see ref. 1). The former three peptides are derived from the SP gene (2, 3), whereas NKB is derived from a separate gene (2-4). In rats, the SP gene primary transcript is differentially spliced into three mRNAs called a-, /3-, and y-preprotachykinin (PPT). The ,B-PPT mRNA possesses the full complement of exons (2, 3) and can be translated (5) and processed posttranslationally to yield SP and NKA and/or NPK (1,3,5,6). The primary structures of these mammalian tachykinin peptides are displayed in Fig. 1.NPK is an N-terminally extended form of NKA and appears to be a final product of P3-PPT posttranslational processing in some tissues (6-8). A comparison of the primary structure of this 36-amino acid-containing peptide from bovine (2), human (9), porcine (6), and rat (3) species reveals a striking sequence homology of 97-100%. NPK is a potent tachykinin peptide originally isolated from porcine brain (6) and appears to be differentially distributed in the central nervous system of the rat (7,8). Tatemoto et al. (6) originally showed that NPK was a potent tachykinin peptide with interesting effects in a bronchoconstriction assay and on systemic arterial blood pressure. Ci/mmol (1 Ci = 37 GBq), was from Amersham. All other chemicals were from Sigma and were the highest purity available. Salivation Bioassays. For dose-response studies, peptides (nmol/kg) were injected intravenously into the femoral vein of rats that were anesthetized with sodium pentobarbital (35 mg/kg; intraperitoneal injection). Male rats of the SpragueDawley strain (Holtzmann, Ma...